Evolent Health A Aktie
3,66
EUR
-0,12
EUR
-3,17
%
4,34
USD
+0,06
USD
+1,40
%
Werbung
Evolent Health A Aktie Analyse
| 01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
| 13.07.16 | Evolent Health A Outperform | FBR Capital | |
| 29.03.16 | Evolent Health A Outperform | FBR Capital | |
| 06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung